Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
paclitaxel (taxol) (1 trial)
Arterial Occlusive Diseases (Phase 3)
Atherosclerosis (Phase 3)
Peripheral Arterial Disease (Phase 3)
Plaque, Atherosclerotic (Phase 3)
Trials (1 total)
Trial APIs (1 total)